Skip to main content
logo
Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
15.40
-0.90 (-5.52%)
At close: Aug 28, 2026, 4:00 PM EDT
15.42
+0.02 (0.13%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Immunic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
21064906862251
Market Cap Growth
149.15%-28.73%33.02%9.04%-75.28%-20.70%
Enterprise Value
5630329-10142
Last Close Price
15.405.3410.0015.0014.0095.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.65-9.624.892.340.551.98
P/TBV Ratio
1.65-4.892.340.552.67

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.00-0.090.050.050.010.01
Net Debt / Equity Ratio
-1.212.23-1.88-1.57-1.01-0.68
Net Debt / EBITDA Ratio
1.310.140.350.461.331.16
Net Debt / FCF Ratio
1.760.170.410.641.761.03
Quick Ratio
4.970.641.641.999.107.81
Current Ratio
5.050.751.772.129.639.21
Return on Equity (ROE)
-138.17%-1653.15%-424.44%-131.28%-100.01%-65.02%
Return on Assets (ROA)
-66.80%-198.76%-128.79%-68.13%-40.53%-30.30%
Return on Capital Employed (ROCE)
-92.20%1572.20%-524.50%-335.60%-75.40%-58.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-53.10%-151.37%-111.58%-138.24%-193.89%-37.00%
FCF Yield
-41.90%-133.91%-94.39%-105.09%-105.08%-33.16%
Buyback Yield / Dilution
-156.51%-55.42%-126.03%-39.29%-34.52%-51.00%
SEC Filings: 10-K · 10-Q